Compounds specific to adenosine A1 and A3 receptors and uses thereof
US7504407B2 · kind B2 · utility
22Cited by
41References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2002 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Nov 27, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to compounds having the structure:wherein which specifically inhibit the adenosine A1 and A3 receptors and the use of these compounds to treat a disease associated with A3 adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.